Kaléo Enters Into Licensing Agreement With Valeo Pharma For The Canadian Rights to ALLERJECT®(epinephrine injection, USP)

Richmond, Va – Kaléo, a privately held U.S. pharmaceutical company, today announced that

it has entered into a ten-year License, Supply, and Commercialization agreement with Valeo Pharma, a

Canadian pharmaceutical company, for the Canadian rights to ALLERJECT® (epinephrine injection, USP) for the

treatment of severe allergic reactions.

“Patients with life threatening allergies across Canada deserve access to this innovative and potentially

lifesaving product,” said Kaléo President and CEO Ronald Gunn. “Valeo Pharma’s sales force, relationships with

the healthcare community, and commitment to patients make them the ideal partner for ALLERJECT.”

For more information please click here.

Skyphos to Showcase Additive Lithography at the Microfluidics Consortium Open Day in Boston

Skyphos Technologies, a Virginia Tech Corporate Research Center company advancing micro-scale and additive lithography manufacturing, will participate in the Microfluidics Consortium Open Day Meeting in Boston, where the company has been invited to present in the Physical Microfluidics Hotseat and deliver a tabletop demonstration. The Microfluidics Consortium convenes worldwide leaders, from research and industry, bringing …

05/18/2026

Neurocrine Biosciences Completes Acquisition of Soleno Therapeutics

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced the completion of its acquisition of Soleno Therapeutics, Inc., strengthening the company’s leadership in endocrinology and rare disease. The acquisition adds VYKAT™ XR (diazoxide choline) tablets, the first and only approved medicine for hyperphagia in adults and pediatric patients 4 years of age and older with Prader-Willi syndrome, to …

05/15/2026

OsteoStrong Expands in Virginia with New Location in Tysons, Virginia

OsteoStrong, a global leader in skeletal strength conditioning, is expanding in Northern Virginia with a new location in Tysons, Virginia, offering residents a cutting-edge, drug-free solution to improve bone density, strength and overall skeletal health in just 10-minute sessions per week. Located at 8609 Westwood Center Drive, Suite 625, Vienna, VA 22182, OsteoStrong Tysons VA …

News